Shuttle Pharmaceuticals Holdings, Inc. Finalizes Agreements for Phase 2 Clinical Trial Enrollment: Press Release Analysis
Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation trading as SHPH on the Nasdaq Stock Market LLC, recently announced significant progress in their clinical trial endeavors. On October 28, 2024, the company issued a press release detailing the completion of agreements with all six intended site enrollment locations for the administration of the Phase 2 clinical […]
More Stories
Why Teens Are Struggling to Find Summer Jobs
By Troy Myers Joslyne Baird has been looking for a job for about a year to help her family pay...
Pentagon Awards Major Tomahawk Missile Contract
By Timothy Frudd The Department of War announced a major contract with a U.S. defense contractor on Aug. 17 to...
DOJ Opens Path to Restore Federal Gun Rights for 30 Million Americans
By Tom Gantert The Justice Department announced on Aug. 17 a new process that will allow eligible individuals prohibited from...
China Used Sex, Donations, Planted Interns to Influence US Political System: Declassified Docs
By Travis Gillmore WASHINGTON— Nearly 150 pages of newly declassified FBI documents paint the clearest picture yet of the relationship...
Apple Business Manager: Login Process, Features, Pricing, and More
Apple Business Manager is a free web-based portal that helps businesses to manage, or you can say organize, different Apple...
Hawaii’s Big Island Prepares as Lala Strengthens to Hurricane Ahead of Possible Landfall
By Jeremy Lott Tropical Storm Lala has strengthened to a hurricane and could be the first to make landfall over...